BrainCheck, a Houston based cognitive healthcare platform built for physicians, raised $8M in Series A funding.
The round was co-led by S3 Ventures and Tensility Venture Partners, with participation from True Wealth Ventures and Nueterra Capital. In conjunction with the funding, Charlie Plauche, partner at S3 Ventures, will be joining the board.
The company intends to use the funds:
– grow its presence among physician groups,
– continue to expand into enterprise healthcare market, and
– conduct research and development by personalizing its algorithm for an improved overall patient experience.
Founded in 2015 by neuroscientists and technologists Dr. David Eagleman (Baylor College of Medicine / Stanford) and Dr. Yael Katz, BrainCheck provides a digital platform that uses tests administered from an iPhone, iPad or desktop computer to interpret a patient’s current level of cognitive function and create a personalized treatment plan. The platform also utilizes AI to compare each patient’s test results with a multi-modal data set, where traditional computerized tests analyze only the individual’s responses.
BrainCheck is used in over 200 clinical practices and by 100,000 people around the world to detect cognitive changes early and enable patients, caregivers, and clinicians to work together to implement personalized recommendations to preserve brain health and functional independence.